The 2-cycle increase in sPD-L1 concentration during ICI treatment may reflect expansion of tumor volume or tumor lysis; we believe that the former was the main reason for this in PD patients and that the latter was the main reason in PR patients. The gene discussed is SPDL1; the disease is neoplasm.